Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature

<table>Graphic summary of biochemical liver injury with administration of adalimumab in Subject 3. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP).</table>

Case Reports in Gastrointestinal Medicine

fig1

Figure 1

Figure 1: Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature 